These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
843 related items for PubMed ID: 22327622
1. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, Curran JA, Balasubramanian S, Bloom T, Brennan KW, Donahue A, Downing SR, Frampton GM, Garcia L, Juhn F, Mitchell KC, White E, White J, Zwirko Z, Peretz T, Nechushtan H, Soussan-Gutman L, Kim J, Sasaki H, Kim HR, Park SI, Ercan D, Sheehan CE, Ross JS, Cronin MT, Jänne PA, Stephens PJ. Nat Med; 2012 Feb 12; 18(3):382-4. PubMed ID: 22327622 [Abstract] [Full Text] [Related]
9. [Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation]. Zhong S, Zhang H, Bai D, Gao D, Zheng J, Ding Y. Zhonghua Bing Li Xue Za Zhi; 2015 Sep 12; 44(9):639-43. PubMed ID: 26705279 [Abstract] [Full Text] [Related]
11. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, Han J, Jeong JY, Shim HS, Cho BC, Kim J, Ahn MJ, Mao M. J Mol Diagn; 2014 Mar 12; 16(2):229-43. PubMed ID: 24418728 [Abstract] [Full Text] [Related]
13. Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer. Kodama T, Tsukaguchi T, Satoh Y, Yoshida M, Watanabe Y, Kondoh O, Sakamoto H. Mol Cancer Ther; 2014 Dec 12; 13(12):2910-8. PubMed ID: 25349307 [Abstract] [Full Text] [Related]
15. RET fusion genes in Korean non-small cell lung cancer. Yoo SS, Jin G, Jung HJ, Hong MJ, Choi JE, Jeon HS, Lee SY, Lim JO, Park JY. J Korean Med Sci; 2013 Oct 12; 28(10):1555-8. PubMed ID: 24133367 [Abstract] [Full Text] [Related]
17. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers. Aisner DL, Nguyen TT, Paskulin DD, Le AT, Haney J, Schulte N, Chionh F, Hardingham J, Mariadason J, Tebbutt N, Doebele RC, Weickhardt AJ, Varella-Garcia M. Mol Cancer Res; 2014 Jan 12; 12(1):111-8. PubMed ID: 24296758 [Abstract] [Full Text] [Related]
18. Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach. Yoon HJ, Sohn I, Cho JH, Lee HY, Kim JH, Choi YL, Kim H, Lee G, Lee KS, Kim J. Medicine (Baltimore); 2015 Oct 12; 94(41):e1753. PubMed ID: 26469915 [Abstract] [Full Text] [Related]
20. Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion. Furugaki K, Mochizuki M, Kohno M, Shu S, Harada N, Yoshimura Y. BMC Cancer; 2019 Apr 03; 19(1):301. PubMed ID: 30943926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]